High expression of Pyrroline-5-Carboxylate Reductase-1 (PYCR1), along with elevated levels of proline and NADH, suggests increased proline biosynthesis in high wGII tumors, potentially supporting cancer cell proliferation and survival under hypoxic conditions. This evidence concerns the gene PYCR1 and cancer.